Analysis of Drugs in Blood to Support the UK Section 5 Driving Under the Influence of Drugs Act

Importance of the Topic

Driving under the influence of drugs is a major factor in road traffic accidents and public safety. In the UK, Section 5A of the Road Traffic Act 1988 sets legal blood concentration limits for specified drugs, both prescribed and illicit. Sensitive and reliable analytical methods are essential to enforce these limits and support forensic toxicology laboratories in providing accurate results under stringent legal requirements.

Objectives and Study Overview

This study describes a streamlined workflow for quantifying 17 target drugs in human whole blood. The goals were to develop a single robust sample preparation protocol and two complementary UPLC-MS/MS methods capable of detecting all specified analytes at levels below UK legislative thresholds, while maintaining high throughput and minimal sample volume.

Methodology

Whole blood (100 µL) was spiked with drug standards and internal standards, then precipitated with zinc sulfate/ammonium acetate. Phospholipids and proteins were removed using a Waters Ostro Pass-Through Sample Preparation Plate. The eluant was split into two aliquots, dried, and reconstituted separately for:

• THC and related cannabinoids in 50% acetonitrile with 0.05% formic acid
• All other drugs in 10% acetonitrile with 0.05% formic acid

The processed samples were analyzed by UPLC-MS/MS using a BEH C18 column (2.1 × 100 mm, 1.7 µm) with 0.05% formic acid in water and acetonitrile as mobile phases. Two gradient programs were applied: one starting at 50% organic for cannabinoids and one at 2% organic for the remaining compounds. The Xevo TQ-S micro mass spectrometer operated in positive ESI mode with two MRM transitions per analyte and one transition per internal standard.

Used Instrumentation

• Waters Ostro Pass-Through Sample Preparation Plate (p/n 186005518)
• ACQUITY UPLC I-Class system with Flow-Through-Needle autosampler
• ACQUITY UPLC BEH C18 column (2.1 × 100 mm, 1.7 µm, p/n 186002352)
• Xevo TQ-S micro Triple Quadrupole Mass Spectrometer
• Ultravap Mistral evaporator for sample drying

Main Results and Discussion

Both UPLC-MS/MS workflows achieved chromatographic separation of all analytes within a single platform. THC at 1 ng/mL was baseline resolved alongside its metabolites on the cannabinoid method, while all other drugs at 10 ng/mL were separated with sharp, well-defined peaks. Sensitivity exceeded the requirements of the UK Section 5A limits, delivering consistent quantitation below the specified thresholds.

Benefits and Practical Applications

• A single sample preparation protocol covers a broad range of drug classes, reducing method complexity.
• Low specimen volume (100 µL) preserves limited forensic samples for confirmatory tests.
• Automatable Ostro plate workflow accelerates processing for high–throughput laboratories.
• High sensitivity and selectivity of UPLC-MS/MS ensure reliable compliance with legal limits.

Future Trends and Applications

Emerging trends include further automation of sample handling and integration with laboratory information systems for seamless data management. Expansion of target panels to include designer drugs and new psychoactive substances will address evolving forensic needs. High-resolution mass spectrometry may complement triple quadrupole methods for non-targeted screening and metabolite profiling.

Conclusion

The described workflow provides a robust, sensitive, and efficient solution for quantifying a wide range of drugs in whole blood at concentrations mandated by UK legislation. By combining minimal sample volume requirements, automated sample cleanup, and dual UPLC-MS/MS methods, laboratories can achieve reliable results with high throughput and regulatory compliance.

References

1. The Drug Driving (Specified Limits) (England and Wales) Regulations 2014 (as amended, Road Traffic Act, England and Wales, 2015 No. 2015).
2. Honkanen R et al. Role of Drugs in Traffic Accidents. British Medical Journal, 281, 1309–1312 (1980).
3. Drummer OH et al. The Involvement of Drugs in Drivers of Motor Vehicles Killed in Australian Road Traffic Crashes. Accident Analysis & Prevention, 36, 239–248 (2004).